Many misdiagnosis claims in our area share a similar pattern: the patient presents with symptoms, the first facility provides an initial read or risk assessment, and then the case depends on follow-up that doesn’t occur quickly enough.
That breakdown might involve:
- A missed or delayed follow-up recommendation after abnormal test results
- An imaging or lab interpretation that doesn’t align with the patient’s symptoms
- A referral that takes longer than it should due to scheduling bottlenecks
- Documentation that doesn’t clearly show what was communicated and when
And when automated tools are part of the workflow—such as clinical decision support, automated risk scoring, or assistive documentation—questions become more specific: Was the tool treated as advisory or assumed to be definitive? Were limitations communicated? Did the team reconcile the output with objective findings?


